BRANMOOR
THURSDAY · 14 MAY 2026

FDA Recall D-0389-2015

Hospira Inc. · Lake Forest, IL

Class I — life-threatening Terminated 801 days on record

Highest impact — Class I recall — FDA determination of strong likelihood of serious adverse health consequence or death.

Product

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30.

Lot / code: One shipment of Lot #: 33-750-DJ; Exp 1SEP2015 to The Harvard Drug Group, Livonia, MI

Quantity: 2,500 vials

Reason for recall

Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.

Recall record

Recall number
D-0389-2015
Classification
Class I
Status
Terminated
Voluntary or mandated
Voluntary: Firm initiated
Firm notification
Telephone
Distribution
Distribution limited to one shipment to The Harvard Drug Group, Livonia, MI for the lots of Vancomycin 500 mg, Ketorolac tromethamine 60 mg/2 mL (30 mg/mL), and Propofol 1% 200 mg/20 mL (10 mg/mL), these lots remained within the control of the distributor and were not further distributed. Distribution was Nationwide for the Vancomycin 1 g product.
Recall initiated
2014-10-06
Classified by FDA Center
2015-02-13
FDA published
2015-02-25
Terminated
2016-12-15
Recalling firm
Hospira Inc.
Firm location
Lake Forest, IL

Drug identification

Brand name(s)
PROPOFOL
Generic name(s)
PROPOFOL
Manufacturer(s)
Hospira, Inc.
NDC(s)
0409-4699, 0409-6010
Route(s)
INTRAVENOUS

‹ All recalls